Financial Ratios

GKB OPHTHALMICS LTD.

NSE : NABSE : 533212ISIN CODE : INE265D01015Industry : Medical Equipment/Supplies/AccessoriesHouse : GKB
BSE87.22-1.72 (-1.93 %)
PREV CLOSE ( ) 88.94
OPEN PRICE ( ) 92.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 33275
TODAY'S LOW / HIGH ( )84.22 92.80
52 WK LOW / HIGH ( ) 74.1127.95
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-5.72-4.58-4.18-8.28-5.99
   CEPS(Rs)-0.680.351.75-1.391.41
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)54.5960.3265.0169.9368.45
   Tax Rate(%)5.16-0.107.870.0014.61
Margin Ratios
   Core EBITDA Margin(%)-3.95-1.65-2.69-2.86-3.46
   EBIT Margin(%)-5.56-3.60-4.45-11.04-6.11
   Pre Tax Margin(%)-10.96-8.53-10.72-16.32-10.68
   PAT Margin (%)-10.39-8.54-9.88-16.32-9.12
   Cash Profit Margin (%)-1.240.664.14-2.732.14
Performance Ratios
   ROA(%)-5.21-3.91-3.48-6.99-5.33
   ROE(%)-9.95-7.31-6.20-12.45-9.47
   ROCE(%)-3.81-2.24-2.11-6.27-4.56
   Asset Turnover(x)0.500.460.350.430.58
   Sales/Fixed Asset(x)0.650.630.470.540.76
   Working Capital/Sales(x)-6.68-5.51-8.123.965.10
Efficiency Ratios
   Fixed Capital/Sales(x)1.531.582.151.851.31
   Receivable days71.5990.72152.37151.28127.30
   Inventory Days75.0483.1799.9182.01129.55
   Payable days149.42169.94269.89218.06140.10
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)-158.69260.8246.75-31.0465.79
   Price/Book(x)1.991.531.260.611.35
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)2.362.102.400.841.52
   EV/Core EBITDA(x)65.8437.4118.5432.7629.53
   EV/EBIT(x)-42.51-58.29-53.86-7.57-24.93
   EV/CE(x)1.240.980.840.350.79
   M Cap / Sales1.971.711.940.851.41
Growth Ratio
   Net Sales Growth(%)2.5226.73-16.50-16.10-17.47
   Core EBITDA Growth(%)-34.34-45.14323.62-58.492211.55
   EBIT Growth(%)-58.48-2.2966.30-51.64-22.91
   PAT Growth(%)-24.72-9.6049.47-50.14-7.88
   EPS Growth(%)-24.72-9.6049.47-38.233.44
Financial Stability Ratios
   Total Debt/Equity(x)0.410.390.370.280.32
   Current Ratio(x)0.760.740.881.321.31
   Quick Ratio(x)0.420.460.541.090.96
   Interest Cover(x)-1.03-0.73-0.71-2.09-1.34
   Total Debt/Mcap(x)0.200.250.290.460.23

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.